The PCPH oncoprotein antagonizes the proapoptotic role of the mammalian target of rapamycin in the response of normal fibroblasts to ionizing radiation

Cancer Research

Volumn 63, Issue 19, 2003, Pages 6290-6298

  Tirado, Oscar M ^a   Mateo Lozano, Silvia ^a   Sanders, Sean ^a   Dettin, Luis E ^a   Notario, Vicente ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE; CASPASE 3; DNA FRAGMENT; GENE PRODUCT; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; ONCOPROTEIN; PCPH PROTEIN; PROTEIN KINASE C; PROTEIN P53; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DOSE RESPONSE; DRUG ACTIVITY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; FIBROBLAST; GENE FUNCTION; GENE INDUCTION; GENE TARGETING; IONIZING RADIATION; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RADIATION DOSE; TRANSCRIPTION INITIATION;

ANIMALS; APOPTOSIS; CELL NUCLEUS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, RADIATION; FIBROBLASTS; MICE; MITOCHONDRIA; ONCOGENE PROTEINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; RADIATION TOLERANCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; SIROLIMUS; SWISS 3T3 CELLS; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 0141885091     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Wash. DC), 281: 1309-1312, 1998.
2. Rich, T., Allen, R. L., and Wyllie, A. H. Defying death after DNA damage. Nature (Lond.), 407: 777-783, 2000.
3. Abraham, R. T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev., 15: 2177-2196, 2001.
4. Ashcroft, M., Taya, Y., and Vousden, K. H. Stress signals utilize multiple pathways to stabilize p53. Mol. Cell. Biol., 20: 3224-3233, 2000.
5. Higashimoto, Y., Saito, S., Tong, X-H., Hong, A., Sakaguchi, K., Appella, E., and Anderson, C. W. Human p53 is phosphorylated on serines 6 and 9 in response to DNA damage-inducing agents. J. Biol. Chem., 275: 23199-23203, 2000.
6. 46, in response to ionizing radiation. J. Biol. Chem., 277: 12491-12494, 2002.
7. Abraham, R. T. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. Curr. Opin. Immunol., 10: 330-336, 1998.
8. Castedo, M., Ferri, K. F., Blanco, J., Roumier, T., Larochette, N., Barretina, J., Amendola, A., Nardacci, R., Mètivier, D., Este, J. A., Piacentini, M., and Kroemer, G. Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J. Exp. Med., 194: 1097-1110, 2001.
9. Castedo, M., Roumier, T., Blanco, J., Ferri, K. F., Barretina, J., Tintignac, L. A., Andreau, K., Perfettini, J. L., Amendola, A., Nardacci, R., Leduc, P., Ingber, D. E., Druillennec, S., Roques, B., Leibovitch, S. A., Vilella-Bach, M., Chen, J., Este, J. A., Modjtahedi, N., Piacentini, M., and Kroemer, G. Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope. EMBO J., 21: 4070-4080, 2002.
10. Banin, S., Moyal, L., Shieh, S., Taya, Y., Anderson, C. W., Chcssa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., and Ziv, Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science (Wash. DC), 281: 1674-1677, 1998.
11. Canman, C. E., Lim, D. S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., and Siliciano, J. D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science (Wash. DC), 281: 1677-1679, 1998.
12. Tee, A. R., and Proud, C. G. DNA-damaging agents cause inactivation of translational regulators linked to mTOR signalling. Oncogene, 19: 3021-3031, 2000.
13. Castedo, M., Ferri, K. F., and Kroemer, G. Mammalian target of rapamycin (mTOR): pro- and anti-apoptotic. Cell Death Differ., 9: 99-100, 2002.
14. Harada, H., Andersen, J. S., Mann, M., Terada, N., and Korsmeyer, S. J. p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD. Proc. Natl. Acad. Sci. USA, 98: 9666-9670, 2001.
15. Eshleman, J. S., Carlson, B. L., Mladek, A. C., Kastner, B. D., Shide, K. L., and Sarkaria, J. N. Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy. Cancer Res., 62: 7291-7297, 2002.
16. Velasco, J. A., Castro, R., Avila, M. A., Laborda, J., DiPaolo, J. A., Cansado, J., and Notario, V. cph, a novel oncogene which cooperates with H-ras in the transformation of NIH/3T3 fibroblasts. Oncogene, 9: 2065-2069, 1994.
17. Velasco, J. A., Zimonjic, D. B., Popescu, N. C., Cansado, J., DiPaolo, J. A., Albor, A., and Notario, V. Tissue-specific expression, evolutionary conservation and localization of the cph proto-oncogene on Syrian hamster chromosome X. Oncogene, 12: 2713-2717, 1996.
18. Blánquez, M. J., Regadera, J., Mariño, J., Newman, R. E., and Notario, V. Gradual deregulation and loss of PCPH expression in the progression of human laryngeal ncoplasia. Mol. Carcinog., 35: 186-195, 2002.
19. Rouzaut, A., Recio, J. A., and Notario, V. Expression of the protein product of the PCPH proto-oncogene in human tumor cell lines. Radiat. Res., 155: 181-187, 2001.
20. Solanas, M., Escrich, E., Rouzaut, A., Costa, I., and Notario, V. Deregulated expression of the PCPH proto-oncogene in rat mammary tumors induced with 7,12-dimethylbenz(a)anthracene. Mol. Carcinog., 33: 219-227, 2002.
21. Recio, J. A., Páez, J. G., Sanders, S., Kawakami, T., and Notario, V. Partial depletion of intracellular ATP mediates the stress-survival function of the PCPH oncoprotein. Cancer Res., 62: 2690-2694, 2002.
22. Velasco, J. A., Avila, M. A., and Notario, V. The product of the cph oncogene is a truncated, nucleotide binding protein that enhances cellular survival to stress. Oncogene, 18: 689-701, 1999.
23. Páez, J. G., Recio, J. A., Rouzaut, A., and Notario, V. Identity between the PCPH proto-oncogene and the CD39L4 (ENTPD5) ectonucleoside triphosphate diphosphohydrolase gene. Int. J. Oncol., 19: 1249-1254, 2001.
24. Prasad, S., Notario, V., Sharareh, S., and Dritschilo, A. Poly(ADP-ribose) polymerase in HeLa cells-a high resolution two-dimensional gel analysis. Appl. Theor. Electrophoresis, 4: 3-10, 1994.
25. Phillips, H. J. Dye exclusion tests for cell viability. In: P. F. Kruse and M. K. Patterson (eds.), Tissue Culture. Methods and Applications, pp. 406-408. New York: Academic Press, 1973.
26. Grinthal, A., and Guidotti, G. Substitution of His59 converts CD39 apyrase into an ADPase in a quaternary structure dependent manner. Biochemistry, 39: 9-16, 2000.
27. Hicks-Berger, C. A., Yang, F., Smith, T. M., and Kirley, T. L. The importance of histidine residues in human ecto-nucleoside triphosphate diphosphohydrolase-3 as determined by site-directed mutagenesis. Biochim. Biophys. Acta, 1547: 72-81, 2001.
28. Schulte am Esch, J., II, Sevigny, J., Kaczmarek, E., Siegel, J. B., Imai, M., Koziak, K., Beaudoin, A. R., and Robson, S. C. Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity. Biochemistry, 38: 2248-2258, 1999.
29. Smith, T. M., Lewis Carl, S. A., and Kirley, T. L. Mutagenesis of two conserved tryptophan residues of the E-type ATPases: inactivation and conversion of an ectoapyrase to an ecto-NTPase. Biochemistry, 38: 5849-5857, 1999.
30. Smith, T. M., and Kirley, T. L. Site-directed mutagenesis of a human brain ectoapyrase: evidence that the E-type ATPases are related to the actin/heat shock 70/sugar kinase superfamily. Biochemistry, 38: 321-328, 1999.
31. Yang, F., Hicks-Berger, C. A., Smith, T. M., and Kirley, T. L. Site-directed mutagenesis of human nucleoside triphosphate diphosphohydrolase 3: the importance of residues in the apyrase conserved regions. Biochemistry, 40: 3943-3950, 2001.
32. Miura, M., Watanabe, H., Okochi, K., Sasaki, T., and Shibuya, H. Biological response to ionizing radiation in mouse embryo fibroblasts with a targeted disruption of the DNA polymerase β gene. Radiat. Res., 153: 773-780, 2000.
33. Sekulif, A., Hudson, C. C., Homme, J. L., Yin, P., Otterness, D. M., Karnitz, L. M., and Abraham, R. T. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res., 60: 3504-3513, 2000.
34. Kim, J. E., and Chen, J. Cytoplasmic-nuclear shuttling of FKBP12-rapamycin-associated protein is involved in rapamycin-sensitive signaling and translation initiation. Proc. Natl. Acad. Sci. USA, 97: 14340-14345, 2000.
35. Desai, B. N., Myers, B. R., and Schreiber, S. L. FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc. Natl. Acad. Sci. U S A, 99: 4319-4324, 2002.
36. Zhang, X., Shu, L., Hosoi, H., Murti, K. G., and Houghton, P. J. Predominant nuclear localization of mammalian target of rapamycin in normal and malignant cells in culture. J. Biol. Chem., 277: 28127-28134, 2002.
37. Abraham, R. T., and Wiederrecht, G. J. Immunopharmacology of rapamycin. Annu. Rev. Immunol., 14: 483-510, 1996.
38. Dumont, F. J., and Su, Q. Mechanism of action of the immunosuppressant rapamycin. Life Sci., 58: 373-395, 1996.
39. Duriez, P. J., and Shah, G. M. Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death. Biochem. Cell Biol., 75: 337-349, 1997.
40. Yamakawa, H., Banno, Y., Nakashima, S., Yoshimura, S., Sawada, M., Nishimura, Y., Nozawa, Y., and Sakai, N. Crucial role of calpain in hypoxic PC12 cell death: calpain, but not caspases, mediates degradation of cytoskeletal proteins and protein kinase C-α 32 and -δ. Neurol. Res., 23: 522-530, 2001.
41. Chao, C., Saito, S., Anderson, C. W., Appella, E., and Xu, Y. Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage. Proc. Natl. Acad. Sci. USA, 97: 11936-11941, 2000.
42. Lohrun, M. A. E., and Vousden, K. H. Regulation and activation of p53 and its family members. Cell Death Differ., 6: 1162-1168, 1999.
43. Chao, C., Saito, S., Kang, J., Anderson, C. W., Appella, E., and Xu, Y. p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J., 19: 4967-4975, 2000.
44. Han, J., Flemington, C., Houghton, A. B., Gu, Z., Zambetti, G. P., Lutz, R. J., Zhu, L., and Chittenden, T. Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc. Natl. Acad. Sci. USA, 98: 11318-11323, 2001.
45. Nakano, K., and Vousden, K. H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell, 7: 683-694, 2001.
46. Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., and Taya, Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell, 102: 849-862, 2000.
47. Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., and Tanaka, N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science (Wash. DC), 288: 1053-1058, 2000.
48. Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., and Vogelstein, B. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol. Cell., 7: 673-682, 2001.
49. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell, 80: 293-299, 1995.
50. Huang, D. C. S., and Strasser, A. BH3-only proteins-essential initiators of apoptotic cell death. Cell, 103: 839-842, 2000.
51. Schuler, M., Bossy-Wetzel, E., Goldstein, J. C., Fitzgerald, P., and Green, D. R. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J. Biol. Chem., 275: 7337-7342, 2000.
52. Yu, J., Wang, Z., Kinzler, K. W., Vogelstein, B., and Zhang, L. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc. Natl. Acad. Sci. USA, 100: 1931-1936, 2003.
53. Dennis, P. B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S. C., and Thomas, G. Mammalian TOR: a homeostatic ATP sensor. Science (Wash. DC), 294: 1102-1105, 2001.
54. Gossen, M., and Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA, 89: 5547-5551, 1992.
55. Yarosh, D. B., Cruz, P. D., Dougherty, I., Bizios, N., Kibitel, J., Goodtzova, K., Both, D., Goldfarb, S., Green, B., and Brown, D. FRAP DNA-dependent protein kinase mediates a late signal transduced from ultraviolet-induced DNA damage. J. Investig. Dermatol., 114: 1005-1010, 2000.
56. Fingar, D. C., Salama, S., Tsou, C., Harlow, E., and Blenis, J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev., 16: 1472-1487, 2002.
57. Ferri, K. F., Jacotot, E., Blanco, J., Este, J. A., Zamzami, N., Susin, S. A., Xie, Z., Brothers, G., Reed, J. C., Penninger, J. M., and Kroemer, G. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: role of mitochondria and caspases. J. Exp. Med., 192: 1081-1092, 2000.
58. Recio, J. A., Páez, J. G., Maskeri, B., Loveland, M., Velasco, J. A., and Notario, V. Both normal and transforming PCPH proteins have guanosine diphosphatase activity, but only the oncoprotein co-operates with Ras in activating extmcellular signal-regulated kinase ERKI. Cancer Res., 60: 1720-1728, 2000.
59. Chen, J., and Fang, Y. A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling. Biochem. Pharmacol., 64: 1071-1077, 2002.
60. Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A., and Chen, J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science (Wash. DC), 294: 1942-1945, 2001.
61. Avila, M. A., Otero, G., Cansado, J., Dritschilo, A., Velasco, J. A., and Notario, V. Activation of phospholipase D: alternative signal transduction pathway responsive to γ-radiation. Cancer Res., 53: 4474-4476, 1993.
62. Dunkirk, S. G., Wallert, M. A., Baumgartner, M. L., and Provost, J. J. Isolation and characterization of a 66-kDa protein from rat liver plasma membrane with RhoA-stimulated phospholipase D activity. Protein Expr. Purif., 24: 1-12, 2002.
63. Blagosklonny, M. V., and Darzynkiewicz, Z. Cyclotherapy: protection of normal cells and unshielding of cancer cells. Cell Cycle, 1: 375-382, 2002.
64. Hidalgo, M., and Rowinsky, E. K. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene, 19: 6680-6686, 2000.